The worst thing about all of this is that if we do get an FDA...

The worst thing about all of this is that if we do get an FDA approval on Ryoncil on or about 31 March, it's going to come in the midst of the galactic crap storm that is the COVID-19 pandemic.

That's likely to seriously drown out the magnitude of a Ryoncil announcement - one of the very, very few stem cell-based therapies ever to be approved by the FDA.

Given that, I am really hoping we get a one-two punch, where the FDA not only approves Ryoncil--but then goes right ahead and agrees to immediate emergency trials for Ryoncil (Remestemcel-L) in COVID-19 cases.

It seems a no-brainer, where the Ryoncil announcement will already be based on and be able to tout efficacy AND safety.

Given that, any emergency trial announcement would be able to heavily play up the fact that the product has already been subjected to the FDA's rigourous approval process for AGvHD (okay, less rigourous all the time these days at the FDA, but still...) and has been shown to have NO side effects (as opposed to other proposed treatments!), thereby pushing MSB's solution right to the head of the queue for treatment of ARDS, and possible quick uptake by other countries like Spain and Italy for testing there, too.

That 1-2 punch might be just enough to ameliorate the outsized impact that this panic selling is having on MSB's SP.